Your browser doesn't support javascript.
loading
[Inhibitory effect of diethylstilbestrol on clinical strains of Candida albicans susceptible and resistant to azoles]. / Efecto inhibitorio del dietilestilbestrol sobre aislamientos clínicos de Candida albicans sensibles y resistentes a los azoles.
Muthular, Milagros; Passero, Pablo; Bálsamo, Fernanda; Jewtuchowicz, Virginia; Miozza, Valeria; Brusca, María Isabel; Pérez, Cristina.
Afiliação
  • Muthular M; Farmacología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Passero P; Farmacología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Bálsamo F; Radiología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Jewtuchowicz V; Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Miozza V; Farmacología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Brusca MI; Microbiología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Pérez C; Farmacología, Facultad de Odontología, Universidad de Buenos Aires, Buenos Aires, Argentina. Electronic address: cristina.perez@odontologia.uba.ar.
Rev Iberoam Micol ; 36(3): 115-119, 2019.
Article em Es | MEDLINE | ID: mdl-31300300
BACKGROUND: Candida albicans is a microorganism frequently involved in several infections; the patient's oral cavity, caries niches or periodontal disease can sometimes be the reservoir.. The fungal resistance to the available treatments, among other reasons, has led to the search for new antifungal alternatives. AIMS: To carry out a comparative study of the in vitro effects of diethylstilboestrol (DES) and fluconazole (FLZ) on the growth of clinical strains of C. albicans. METHODS: Seven strains of C. albicans were used: a) one FLZ-sensitive culture collection strain, ATCC 90028 (ATCC); b) four oral isolates from four oncological patients with periodontal disease (period 8, 9, 10, and 11); and c) two oral isolates from an AIDS patient with oropharyngeal candidiasis: one FLZ- sensitive (2-76), and another FLZ- resistant (12-99). The MIC was evaluated by standard spectrophotometric techniques using the CLSI (M27-A3) guidelines. The inhibitory concentration 50% (IC50) was calculated using functional analysis with the Graph Pad software. RESULTS: DES inhibited the growth of all C. albicans strains, whether sensitive or resistant to FLZ. Experimental data fitted non-linear functions of inhibitor concentration versus response. Minimum inhibitory concentrations (MIC) for DES and FLZ were as follows: 28.18µg/ml and 4.90µg/ml (ATCC); 17.16µg/ml and 3.14µg/ml (period); 27.64µg/ml and 4.22µg/ml (2-76); 6.16µg/ml and 438.19µg/ml (12-99), respectively. CONCLUSIONS: DES showed antifungal activity on all clinical C. albicans strains isolated from patients with dental and medical diseases. It showed the highest potency on the FLZ-resistant isolate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Fluconazol / Farmacorresistência Fúngica / Dietilestilbestrol / Antifúngicos Tipo de estudo: Guideline Limite: Humans Idioma: Es Revista: Rev Iberoam Micol Assunto da revista: MICROBIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Argentina País de publicação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Fluconazol / Farmacorresistência Fúngica / Dietilestilbestrol / Antifúngicos Tipo de estudo: Guideline Limite: Humans Idioma: Es Revista: Rev Iberoam Micol Assunto da revista: MICROBIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Argentina País de publicação: Espanha